Skip to content
Sign in

Checklist · Biotech

Biotech Launch Checklist for 2026

Biotech launches demand regulatory rigor and clinical depth from day one. Use this phased checklist to align research, compliance and go-to-market. [launch guides](/resources/launch-guides) walk step-by-step.

9 checklist items Updated from migrated LaunchTry SEO content

Phase 01

Foundation

3 tasks
  • c1
    high2-3 days

    Define goals and KPIs (Biotech)

    Write KPIs for regulatory approval timeline, clinical efficacy, safety thresholds and market adoption. Align internal teams on what 'launch success' means in your regulatory pathway.

  • c2
    medium1 week

    Identify target audience (Biotech)

    Map decision-makers at hospitals, labs, pharma buyers and patients. Identify gatekeepers in your reimbursement chain and early-adopter sites willing to pilot.

  • c3
    critical1 day

    Audit current state (Biotech)

    Document your current IP position, manufacturing readiness, clinical data gaps and regulatory pathway. Audit vendor and partner alignment against your launch date.

Phase 02

Execution

3 tasks
  • c4
    critical1 day

    Prioritize high-impact tasks (Biotech)

    Rank regulatory approvals, clinical evidence generation and manufacturing scale-up by impact and timeline. Ruthlessly cut non-critical dependencies.

  • c5
    high2-3 days

    Assign owners and deadlines (Biotech)

    Assign regulatory affairs, clinical ops and commercial leads with hard deadlines tied to reimbursement timelines and clinical milestones.

  • c6
    high2-3 days

    Set up tracking (Biotech)

    Build dashboards for regulatory status, clinical enrollment rates, manufacturing yield and buyer pipeline. Weekly tracking catches slippage early.

Phase 03

Launch & Review

3 tasks
  • c7
    medium1 week

    Ship and verify (Biotech)

    Validate manufacturing at scale, confirm clinical readiness and secure regulatory sign-off before any public announcement. Early shipping = recalls and trust loss.

  • c8
    high2-3 days

    Measure against KPIs (Biotech)

    Compare actual adoption, reimbursement rates and safety profiles against your KPI plan. Biotech surprises often come from adoption, not efficacy.

  • c9
    high2-3 days

    Iterate on results (Biotech)

    Tighten manufacturing, expand clinical follow-up studies and refine buyer positioning based on real-world usage patterns you're now seeing.

Pro tips

  • Tackle critical items first
  • Review the checklist weekly
  • Adapt phases to your biotech context